We have measured secretory patterns of inhibin A, B, total α inhibin, pro-αC inhibin and oestradiol in women following pituitary suppression who were randomised into two groups to receive either urinary gonadotrophin (25:75 IU/ampoule of luteinizing hormone (LH) and follicle stimulating hormone (FSH; Normegon; n ⍧ 11) or recombinant (r)FSH (75 IU/ampoule of FSH alone, n ⍧ 16). The women were of similar age (~33 years) and length of infertility (~4 years) and had a normal endocrine evaluation. Plasma FSH, LH, oestradiol, inhibin A, B, pro-αC and total α inhibin were measured by immunoassay prior to and following gonadotrophin stimulation. Immunoactive FSH, LH and oestradiol blood concentrations following pituitary down regulation were similar in the two groups being <2.0, <3.6 IU/l and <82 pmol/l respectively. The units of FSH given (2230 versus 2764 IU; Normegon versus rFSH), duration of treatment (9.1 versus 9.4 days) and number of follicles of ≥14mm on the day of human chorionic gonadotrophin (HCG) administration (17 versus 14) were also similar. Inhibin A or B concentrations rose similarly during Normegon or rFSH administration, peaking at days 9-11. Total α and pro-αC inhibin concentrations were lower (P < 0.05) in the rFSH group during days 10 and 11 of treatment being 18.9 ⍨ 15.9 ng/ml (Normegon) and 4.6 ⍨ 2.8 ng/ml (rFSH) for total α inhibin and 8.5 ⍨ 6.8 ng/ml (Normegon) and 2.8 ⍨ 1.6 ng/ml (rFSH) for pro-αC inhibin on day 10. Overall, higher total α inhibin concentrations were associated with more mature follicles and oocytes, greater fertilization rates and better quality embryos. We conclude that inhibin A and B secretion was similar in both groups and is primarily controlled by FSH, whereas total α inhibin and pro-αC increased preferentially in the Normegon group over the rFSH group, indicating that they are, in part, stimulated by LH.
Introduction
in serum and ovarian follicular fluid (Knight, 1996) . Moreover, there is some evidence that monomeric inhibin α subunits are Inhibins are heterodimeric glycoproteins consisting of αβ A bioactive in that they may modulate follicular function at the (inhibin A) and αβ B (inhibin B) subunits which are secreted local level by inhibiting the binding of FSH to its receptors mainly by the ovaries in women. Inhibin B is known to be a on granulosa cells (Schneyer et al., 1991) , may reduce bovine selective suppressor of pituitary follicle stimulating hormone oocyte developmental competence in vitro (Silva et al., 1999 ) (FSH) secretion and inhibin A and B have local paracrine and may have a role in the pathogenesis of adrenal tumours actions in the gonads (Knight, 1996; Hayes et al., 1998; (Munro et al., 1999) . The α subunit is also present in precursor Lockwood et al., 1998; Lahlou et al., 1999) . Most of the forms in combination with the β subunits (β A or β B ) to form data indicate that only the dimeric forms of inhibin are pro-αC-containing inhibins. physiologically important in controlling FSH secretion and Inhibin A and B are differentially secreted across the 'fine-tuning' the hypothalamic-gonadal axis (Lockwood et al., menstrual cycle . Inhibin A is thought 1998). Their role in growth and development during human to be a marker of the maturity of the dominant follicle ovulation, conception and pregnancy has recently been (Lockwood et al., 1996) whereas inhibin B is the predominant reviewed (Lockwood et al., 1998) .
form in the smaller antral follicles and may be an indicator of The α subunit is synthesised in excess over the β subunits and several monomeric forms are present in high concentrations ovarian reserve (Lockwood et al., 1996; Seifer et al., 1997) .
With regard to the gonadotrophic control of inhibin secretion, 1992; Mitchell et al., 1996) . Only recently with the advent of subunit which are correlated with the number of follicles developing (Lockwood et al., 1996) . In our experimental model we have examined the role of oestradiol were compared in the two groups of women. Some of these results have been presented in a preliminary form
Oestradiol assay
elsewhere (Fawzy et al., 1998) .
Serum oestradiol concentrations were measured by Delfia kit (Wallac, Milton Keynes, UK) according to the manufacturer's protocol. The assay has a limit of detection of 50 pmol/l and intra-and inter-
Materials and methods
variation of Ͻ10 and Ͻ13% respectively over the range 100-1200 Women presenting with unexplained or tubal infertility at the Human pmol/l. Assisted Reproduction Unit in Ireland (HARI), Rotunda Hospital, Dublin were recruited to take part in this study. The patients were Inhibin A assay endocrine normal and had regular menses. Ethical Committee approval Inhibin A was measured by ELISA using a commercial kit (Serotech, and specific consent to participate were obtained. The study was Kidlington, Oxford, UK). The assay has minimal cross reaction with a randomised, prospective, assessor-blind, comparative study. We inhibin B, pro-αC or activins. The limit of detection is 4 pg/ml and examined the secretory profiles of inh A,B, total inh α, pro-αC intra-and inter-assay variation was Ͻ6 and Ͻ16% respectively over and oestradiol in women following pituitary down-regulation with the working range 4-500 pg/ml. buserelin (long protocol) (Kondaveeti-Gordon et al., 1996) who were randomised to receive either Normegon (25:75 IU/ampoule of Inhibin B assay LH:FSH; n ϭ 11; Organon, Cambridge, UK), or rFSH (75 IU/ Inhibin B was measured by ELISA using a commercial kit (Serotech, ampoule of FSH alone: Puregon and Gonal-F, rFSH; Sereno, Welwyn Kidlington, Oxford, UK). The assay has minimal cross reaction with Garden City, Herts, UK). Puregon and Gonal-F are similar both with inhibin pro-αC or activins, and~1% cross reaction with inhibin A. respect to their physiochemical and biological characterisation and
The limit of detection is 16 pg/ml and intra-and inter-assay variation clinical efficacy (Brinsden et al., 2000; Horsman et al., 2000) .
was Ͻ6 and Ͻ13% respectively over the working range 16-1000 Furthermore in this study no differences were observed in response pg/ml. to the two preparations (Puregon, n ϭ 10 patients and Gonal-F, n ϭ 6 patients) and therefore the data were combined into a single rFSH Inhibin pro-αC assay group (n ϭ 16).
Inhibin pro-αC was measured by ELISA using a commercial kit This was the first IVF cycle the women had undertaken. They (Serotech, Kidlington, Oxford, UK). The assay has less than 0.1% were of similar age mean (range) 33 (24-39) years and length of crossreactivity with inhibin-A, inhibin-B, activin-A, activin-B and infertility mean (range) 4 (2-8) years (Table I) . IVF treatment was follistatin. The limit of detection is 2 pg/ml and intra-and inter-assay as described previously (Harrison et al., 1992) except they were variation was Ͻ10 and Ͻ15% respectively over the working range randomised to receive Normegon or rFSH. A randomisation code for 2-200 pg/ml. choice of gonadotrophin therapy, blind to the clinician, was computed Total α inhibin by the pharmacist. Blood was taken prior to down regulation (pretreatment), after down regulation (day 0) and on days 5, 8, 9, 10 and Total α inhibin was measured by an α subunit-directed inhibin 11. All post-treatment samples were taken 24 h post gonadotrophin radioimmunoassay (Knight et al., 1989; Muttukrishna et al., 1994) . injection. In addition, in five women from each group blood samples
The detection limit of the assay was 2ng/ml and the mean intra-and were taken 3 h post gonadotrophin injection on day 8 for immunoactive inter-assay coefficients of variation (CV) were 7 and 12% respectively LH analysis. The blood was allowed to clot, serum separated and over the working range 2-12.5 ng/ml. stored at -40°C until hormone assay. Inhibin A FSH and LH immunoassays Muttukrishna et al., 1994) , inhibin B , pro-αC inhibin , total α inhibin (Knight et al., 1989 , Serum samples were assayed for FSH and LH using the appropriate Delfia time-resolved fluorescence immunoassay kits following the 1990), FSH, LH and oestradiol were measured by immunoassay. when appropriate, Spearman's rank correlation coefficient (r) was calculated. manufacturer's instructions. The limit of detection of the serum assay was 1 IU/l (FSH) and 0.6 IU/l (LH) and the intra and inter-assay
Results
CV's were Ͻ6 and Ͻ15% respectively over the range 1-250 IU/l.
Concentrations of LH, FSH and oestradiol in women following
Classification of embryo quality pituitary down regulation were similar in the two groups as were the units of FSH given, duration of treatment and number This was performed 44 h post-insemination as per established criteria (Plachot et al., 1987) .
of follicles of ജ14mm on the day of HCG (Table I) . FSH concentrations were similar throughout Normegon or rFSH on days 9-11. Thus, FSH concentrations in the Normegon For the purposes of calculation, values falling below the limit of group rose from 3.6 Ϯ 1.0 IU/l after down regulation to 11.6 Ϯ detection of the hormone assays were assigned a value halfway 1.6 IU/l (day 5) and to 16.2 Ϯ 7.3 IU/l (day 10) whilst in the between zero and the limit of detection. The data were analysed using rFSH group concentrations rose from 3.5 Ϯ 1.2 IU/l after GraphPad Instat version 3.01 for Windows 95, (GraphPad Software; down regulation to 12.6 Ϯ 2.4 IU/l (day 5) and to 21.4 Ϯ San Diego, California, USA). Log transformation of hormone data 7.1 IU/l (day 10). Immunoreactive LH concentrations were was used to normalise the distribution. Unpaired two-tailed tests similarly low (Ͻ1.6 IU/l) in both groups throughout treatment were used to compare normally distributed continuous variables. Fisher's exact tests were used to compare categorical outcomes and due to the short half-life and consequent clearance in the 24 h Table III . Patient characteristics, hormone concentrations and clinical outcomes in patients with a low α inhibin concentration of Ͻ4 ng/ml (n ϭ 9) and a high α inhibin concentration ജ4 ng/ml (n ϭ 16) in the last days of treatment.
Parameter α inhibin (Ͻ4 ng/ml) α inhibin (ജ4 ng/ml) P value (n ϭ 9) (n ϭ 16) Results presented as mean Ϯ SD (range). P Ͻ 0.05 is significant, NS ϭ non-significant post injection period. In five patients from each group blood Discussion samples were taken for LH analysis 3 h after gonadotrophin
Our experimental design was chosen to allow us to probe injection on day 8. In this small subset of patients LH was the role of LH in the secretion of the various species of higher (P ϭ 0.001) in the Normegon group (2.0 Ϯ 0.7 IU/l) immunoreactive inhibin by comparing their secretory patterns than in the rFSH (1.0 Ϯ 0.2 IU/l) group.
in patients treated either with rFSH, containing no LH, or a Inhibin A and inhibin B concentrations also increased during urinary gonadotrophin preparation, Normegon, containing both both Normegon and rFSH administration, again reaching a FSH and LH, but no added HCG. peak on days 9-11 (Figure 1 ). However, their concentrations
We found immunoactive LH concentrations of~1.6 IU/l were highly variable being 1517 Ϯ 652 pg/ml (Normegon) (Normegon) and~1.1 IU/l (rFSH) 24 h post gonadotrophin versus 1009 Ϯ 408 pg/ml (rFSH) for inhibin A and 1908 Ϯ injection. These concentrations of LH would not reflect peak 917 pg/ml (Normegon) versus 941 Ϯ 418 pg/ml (rFSH) for values as the blood samples were taken 24 h post injection inhibin B respectively on day 10 of treatment ( Figure 1 ). In and LH has a short initial half-life of~1 h and a terminal half contrast, total α and pro-αC concentrations were lower life of 10-12 h (le Cotonnec et al., 1998) . However, in those (P Ͻ 0.05) in the rFSH group during the final days of samples taken 3 h post gonadotrophin injection from five gonadotrophin stimulation being 18.9 Ϯ 15.9 ng/ml (Normewomen from each group on day 8, immunoactive LH was gon) versus 4.6 Ϯ 2.8 ng/ml (rFSH) for total α inhibin and higher in the Normegon group (2.0 Ϯ 0.7 IU/l) than in the 8.5 Ϯ 6.8 ng/ml (Normegon) and 2.8 Ϯ 1.6 ng/ml (rFSH) for rFSH group (1.0 Ϯ 0.2 IU/l). Oestradiol secretion was not pro-αC inhibin on day 10 (Figure 2) . The corresponding results different in the two groups although it tended to be lower in for oestradiol were 5570 Ϯ 3108 pmol/l and 3381 Ϯ the rFSH group suggesting that in some of these patients there 1046 pmol/l (Figure 2) . The hormone production per follicle may have been insufficient endogenous LH to sustain oestradiol ജ14mm is given in Table II and as can be seen the concentrasecretion at the concentrations seen with patients treated with tions of inhibin α and pro-αC per follicle are lower in the Normegon. Our data are in general compatible with previous rFSH group compared with the Normegon group in contrast observations on the threshold concentrations of LH required to oestradiol, and inhibin A and B.
to sustain normal concentrations of oestradiol secretion in In view of the dissociation between total α inhibin secretory stimulated cycles ie ജ1-2 IU/l (Chappel and Howles, 1991; patterns observed in the Normegon and rFSH groups, an Schoot et al., 1992; Mitchell et al., 1996; Fleming et al. , analysis of the relationship between this parameter and clinical 1998). It is clear that, although FSH may be the only factor correlates of IVF outcome were performed. Total α inhibin required to induce follicular growth in the human, LH or a concentrations on days 9-11 were positively correlated with product derived from its action may assist in producing fully the number of mature follicles (r ϭ 0.85; P Ͻ 0.0001), mature mature follicles and oocytes capable of fertilization (Schoot oocytes (r ϭ 0.80; P Ͻ 0.0001) and fertilization rates et al., 1992; Shoham et al., 1993; Balasch et al., 1995) . (r ϭ 0.4; P ϭ 0.03). Moreover, if the patients were divided
We have shown that inhibin A and inhibin B increase on the basis of having a total α inhibin concentration of Ͻ4 progressively in the blood with exogenous gonadotrophin or ജ4 ng/ml it can be seen that the latter group had more treatment and were similar in both the Normegon and rFSH follicles of ജ14mm, more mature oocytes, greater fertilization groups, indicating that they are primarily controlled by FSH. rates but required less gonadotrophin (Table III) . Furthermore, Serum concentrations of inhibin α and pro-αC increased the number of good (grade 1) embryos found in the higher preferentially in the Normegon group in contrast to the rFSH total α inhibin group was 58% compared to 6% in the low group, indicating that they are primarily stimulated by LH. total α inhibin group (Table IV) , in which only two patients had received Normegon.
Moreover, total inhibin and pro-αC concentrations, calculated Plachot et al., 1987) in IVF cycles (n ϭ 61) compared between the α inhibin Ͻ4 ng/ml group and ജ4 ng/ml groups. as the secretion per follicle ജ14mm, was such that the output stimulation treatment might be a good predictor of IVF clinical outcomes (McLachlan et al., 1986; Hughes et al., 1990 ; Matson per follicle was significantly decreased in the rFSH group.
The regulatory mechanisms that give rise to differential et al., 1991; Buckler et al., 1992; Mitchell et al., 1996) . However, this appears incompatible with other evidence indicgranulosa cell expression of inhibin α and inhibin/activin β A and β B subunits during follicle development in primates are ating that inhibin α subunit can compete with FSH for binding to its receptor (Schneyer et al., 1991) and reduce poorly defined but are likely to involve an interplay between gonadotrophins and locally-produced factors including steroids the developmental competence of in-vitro matured, in-vitro fertilized bovine oocytes to form blastocysts (Silva et al. , and peptide growth factors (Knight, 1996) . Expression of β B mRNA is predominant in preantral and small antral follicles 1999). It should be noted, however, that while the number of mature oocytes recovered per subject in the present study was which express relatively little β A and α subunit; this implies that activin B and inhibin B are preferentially synthesized in positively linked to their serum inhibin α concentrations, the percentage developing to the ജ4-cell stage tended to be lower small follicles (Schwall et al., 1990; Roberts et al., 1993) . Pre-ovulatory follicle growth is associated with increased in the group with high inhibin α concentrations (60.5 versus 77.7%, NS). Moreover, developmental competence was only expression of β A and α subunit and decreased expression of β B subunit (Schwall et al., 1990; Roberts et al., 1993) , recorded up to the ജ4 cell stage in the present study, rather than the blastocyst stage as in Silva et al. (1999) . consistent with the finding of increased circulating concentrations of inhibin A, total α inhibin but not inhibin B during the We conclude that inhibin A and inhibin B secretion was similar in both groups and is primarily controlled by FSH spontaneous follicular phase Muttukrishna et al., 1994) most likely in response to the whereas inhibin α and pro-αC secretion was lower in the rFSH group and are primarily stimulated by LH. Moreover, changing concentrations of FSH taking place during the latter stages of the follicular phase of the cycle. Furthermore, the total α inhibin secretion in the final days of treatment was positively correlated with a number of clinical outcomes likely observation that serum inhibin B concentrations rise in parallel with inhibin A during FSH-induced multiple follicular to influence IVF outcome. development in down-regulated, LH-deficient treatment cycles (Lockwood et al., 1996 ; present study) further supports a role
